While this outpatient COVID-19 convalescent plasma meta-analysis indicated heterogeneity in participant risk factors and convalescent plasma titer, the combined efficacy for reducing hospitalization was significant, improving with transfusion within 5 days of symptom onset and high antibody neutralization levels.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, therapy, Hospitalization, COVID-19 convalescent plasma,
【저자키워드】 COVID-19, SARS-CoV-2, therapy, Hospitalization, COVID-19 convalescent plasma,